How dilution can crush biotech returns

Поділитися
Вставка
  • Опубліковано 3 жов 2024

КОМЕНТАРІ • 6

  • @tl5160
    @tl5160 11 місяців тому +3

    As someone who is an early employee of a startup, this video was significantly helpful. Thank you.

  • @leenva
    @leenva 2 роки тому +4

    Thanks, working in biotech and still new; this is absolutely fantastic in understanding what's going on in startup biotechs

  • @rttube555
    @rttube555 Рік тому +2

    Great summary. Need more videos! 🎉

  • @gitsnshiggles
    @gitsnshiggles 2 роки тому +2

    awesome bro!!!

  • @FeynmanX
    @FeynmanX Рік тому +1

    Thanks for sharing this!

  • @Ozzie12
    @Ozzie12 Рік тому

    Thank you for this. Question... I often use operating cash flow for a non-revenue generating companies like biotech. Would that be a reasonable surrogate? I imagine using the income statement might factor in other non-recurring factors? Thanks!